Stocktoria
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI
Recordati Industria Chimica e Farmaceutica S.p.A. statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€21.15); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Recordati Industria Chimica e Farmaceutica S.p.A. trades at about 24.8× earnings — below its 10-year norm (10-year range 21.8×–29.5×, median 27.6×).
Shaded band = 10-year range (21.8×–29.5×); dot = today's 24.8×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 68.3% | 68.3% | 68.3% | 69.4% |
| Operating margin | 27.5% | 28.2% | 27.2% | 26.7% |
| Net margin | 16.9% | 17.8% | 18.7% | 16.9% |
| FCF margin | 19.5% | -12.0% | 4.9% | 19.7% |
| Return on assets | 8.4% | 8.1% | 9.2% | 7.8% |
| Return on equity | 23.1% | 22.2% | 23.1% | 20.2% |
| Current ratio | 1.59 | 1.61 | 1.20 | 1.27 |
Computed from company filings · IT · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.